262 related articles for article (PubMed ID: 28134924)
1. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.
Mousa JJ; Kose N; Matta P; Gilchuk P; Crowe JE
Nat Microbiol; 2017 Jan; 2():16271. PubMed ID: 28134924
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.
Mousa JJ; Sauer MF; Sevy AM; Finn JA; Bates JT; Alvarado G; King HG; Loerinc LB; Fong RH; Doranz BJ; Correia BE; Kalyuzhniy O; Wen X; Jardetzky TS; Schief WR; Ohi MD; Meiler J; Crowe JE
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6849-E6858. PubMed ID: 27791117
[TBL] [Abstract][Full Text] [Related]
3. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
[TBL] [Abstract][Full Text] [Related]
4. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
[TBL] [Abstract][Full Text] [Related]
5. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
6. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.
Ngwuta JO; Chen M; Modjarrad K; Joyce MG; Kanekiyo M; Kumar A; Yassine HM; Moin SM; Killikelly AM; Chuang GY; Druz A; Georgiev IS; Rundlet EJ; Sastry M; Stewart-Jones GB; Yang Y; Zhang B; Nason MC; Capella C; Peeples ME; Ledgerwood JE; McLellan JS; Kwong PD; Graham BS
Sci Transl Med; 2015 Oct; 7(309):309ra162. PubMed ID: 26468324
[TBL] [Abstract][Full Text] [Related]
7. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater
Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.
Wen X; Mousa JJ; Bates JT; Lamb RA; Crowe JE; Jardetzky TS
Nat Microbiol; 2017 Jan; 2():16272. PubMed ID: 28134915
[TBL] [Abstract][Full Text] [Related]
12. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
[TBL] [Abstract][Full Text] [Related]
13. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
Front Immunol; 2019; 10():706. PubMed ID: 30984206
[No Abstract] [Full Text] [Related]
14. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of respiratory syncytial virus neutralization by motavizumab.
McLellan JS; Chen M; Kim A; Yang Y; Graham BS; Kwong PD
Nat Struct Mol Biol; 2010 Feb; 17(2):248-50. PubMed ID: 20098425
[TBL] [Abstract][Full Text] [Related]
16. Alternative conformations of a major antigenic site on RSV F.
Jones HG; Battles MB; Lin CC; Bianchi S; Corti D; McLellan JS
PLoS Pathog; 2019 Jul; 15(7):e1007944. PubMed ID: 31306469
[TBL] [Abstract][Full Text] [Related]
17. Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
Xun G; Song X; Hu J; Zhang H; Liu L; Zhang Z; Gong R
J Virol; 2021 Aug; 95(18):e0048521. PubMed ID: 34160257
[TBL] [Abstract][Full Text] [Related]
18. Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.
Xie Q; Wang Z; Ni F; Chen X; Ma J; Patel N; Lu H; Liu Y; Tian JH; Flyer D; Massare MJ; Ellingsworth L; Glenn G; Smith G; Wang Q
PLoS One; 2019; 14(2):e0210749. PubMed ID: 30730999
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
Swanson KA; Settembre EC; Shaw CA; Dey AK; Rappuoli R; Mandl CW; Dormitzer PR; Carfi A
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9619-24. PubMed ID: 21586636
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
Boyington JC; Joyce MG; Sastry M; Stewart-Jones GB; Chen M; Kong WP; Ngwuta JO; Thomas PV; Tsybovsky Y; Yang Y; Zhang B; Chen L; Druz A; Georgiev IS; Ko K; Zhou T; Mascola JR; Graham BS; Kwong PD
PLoS One; 2016; 11(7):e0159709. PubMed ID: 27463224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
